The Wave

1. 6d agoYahooWuxi Apptec removed from Pentagon list of chinese military companiesThe Pentagon dropped WuXi AppTec from its Chinese military companies list after a Washington federal court blocked enforcement of the designation in the company's lawsuit.

   2 articles

   1. 6d agoYahooEarliestWuxi Apptec removed from Pentagon list of chinese military companies
   2. 6d agoSTATPickupSTAT+: Trump administration removes WuXi AppTec from its Chinese military list

   Biotech2 linked
2. 5h agoSTATSTAT+: FDA rejects lung cancer treatment ivonescimab from Summit TherapeuticsThe FDA issued a complete rejection of Summit Therapeutics and Akeso's lung cancer drug ivonescimab because it did not show an overall survival benefit despite slowing disease progression.1 outletBiotech
3. YesterdayAnthropicLLMs and bioriskAnthropic's Institute publishes internal and public-benchmark evidence that AI is accelerating its own development, and argues that recursive self-improvement could arrive sooner than institutions expect and that a verifiable coordinated slowdown should be an option.

   12 articles

   1. YesterdayAnthropicPolicy on the AI Exponential
   2. YesterdayAnthropicNatural Language Autoencoders
   3. YesterdayAnthropicInvestigating unintended model actions in our evaluations and internal use
   4. YesterdayAnthropicResponsible Scaling Policy Version 3.0
   5. YesterdayAnthropicTrustworthy agents in practice
   6. YesterdayAnthropicPickupThoughts on America’s AI Action Plan
   7. YesterdayAnthropicUnderstanding and addressing AI harms
   8. YesterdayAnthropicTeaching Claude why
   9. YesterdayAnthropicPetri: An open-source AI auditing tool
   10. YesterdayAnthropicLLMs and biorisk
   11. YesterdayAnthropicAnthropic’s Transparency Hub
   12. YesterdayAnthropicEarliestWhen AI builds itself

   BiotechAI236 linked
4. 2d agoNextgov/FCWNational Cancer Institute teases AI-assisted cancer care records retrievalThe National Cancer Institute is weighing an early-stage "Every Patient" initiative to capture cancer data on every U.S. cancer patient using AI, alongside a $200 million AI-enabled therapeutic cancer vaccine effort with the Foundation for the NIH.1 outletBiotechAI5 linked
5. 3d agoFortuneFormer Sen. Roy Blunt: Trump’s latest China crackdown puts American lives on the lineFormer Senator Roy Blunt warns that a Treasury proposal to extend outbound investment limits under the COINS Act to all of biotech would hurt American drugmakers and patients more than China.1 outletBiotech3 linked
6. 3d agoAtlantic CouncilSeeking the source: Biological attribution from anthrax to AIA Bipartisan Commission on Biodefense report warns that AI-designed biological threats could evade current attribution methods and urges the US to unify its fragmented attribution apparatus.1 outletBiotechAI6 linked
7. 4d agoSTATSTAT+: Cassidy sets key vote on Overton, even as he remains undecided on nominee to lead FDASenate HELP Committee schedules a Nov. 18 vote on FDA commissioner nominee Heidi Overton, with Chair Bill Cassidy still undecided.1 outletBiotech2 linked
8. 2d agoSTATSTAT+: HHS plans funding for research into ibogaine for PTSDSTAT reports that HHS plans to fund research into ibogaine for PTSD, though the full story is paywalled and only a newsletter preview is available.1 outletBiotech2 linked
9. 4d agoLos Angeles TimesFor peptide enthusiasts, a new HHS policy means party timeHHS's enforcement discretion policy lets pharmacies compound six unapproved peptides ahead of a final FDA rule, which critics say expands access without adequate safety or efficacy evidence.1 outletBiotech5 linked
10. PN2d agoPR NewswireArmata Pharmaceuticals Announces Financial Results for the Third Quarter 2026 and Provides Corporate UpdateArmata Pharmaceuticals received $3.7 million in additional DoW non-dilutive funding through MTEC for AP-SA02 Phase 3 execution, bringing cumulative award funding to about $32.4 million.1 outletBiotech
11. PN3d agoPR NewswireNew Research Explores Forces Shaping Global Biopharma InnovationThe Eira Initiative published 18 new 2026 working papers examining how IP, pricing, tax incentives and regulation shape global medical innovation, ahead of its Paris conference.1 outletBiotech
12. 6d agoYahooUS FDA orders new eye risk warnings for Ozempic, ZepboundThe FDA ordered GLP-1 weight-loss and diabetes drugs such as Zepbound, Mounjaro, Ozempic and Wegovy to add a potential eye-risk warning (NAION) to their labeling.1 outletBiotech6 linked
13. 4d agoWIRED · research by Radical NumericsA Startup Wants to Fight AI Bioweapons With AIRadical Numerics unveiled Omnii Defense, an AI edge model that flags natural and AI-engineered pathogens from genome sequences, as a biodefense counter to AI-enabled bioweapon risk.1 outletBiotechAI
14. 6d agoProPublicaFirm Linked to Trump’s Sons Got Nearly $40 Million in Federal Contracts to Screen for Ebola and Other DiseasesCDC and State Department awarded XpresTest about $38.8 million total, $18.8 million for Ebola entry screening at U.S. airports and $20 million for Democratic Republic of Congo outbreak response.1 outletBiotech5 linked
15. 4d agoDefense NewsInside Warhound’s plan to engineer a better military working dogWarhound's founders outline a plan to produce a domestic supply of genetically engineered, cloned and early-trained military working dogs, with first animals expected in roughly two years.1 outletBiotechDefense
16. 6d agoYahoo · research by Food and Drug AdministrationFDA warns against online weight-loss drugs containing uncertain ingredientsFDA issued a warning letter to Cheap Medicine Shop and a safety alert on dosing errors, cautioning consumers about unapproved online semaglutide weight-loss injections.1 outletBiotech6 linked
17. 6d agoJohns Hopkins University Applied Physics LaboratoryJohns Hopkins APL Licenses “Safe Buildings” System to Neutralize Biological ThreatsJohns Hopkins APL has licensed its "Safe Buildings" system, which destroys airborne biological agents inside HVAC ducts, to Bio-Defense Research Group for commercial production.1 outletBiotech

Ahead

Recent

Nothing from this branch in view.

Times ET

1. RFPADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)2d agoARPA-H seeks proposals for SURPASS, a simulation-augmented real-time adaptive seamless trial platform, under solicitation ARPA-H-SOL-26-164.Closes in 15 daysARPA-H-SOL-26-164BiotechLifecycle10 linked
2. GrantNational Institutes of Health11d agoNIH seeks applications for a U19 systems biology program on infection, inflammation and chronic disease, with a $26 million ceiling.$26M ceilingCloses in 95 daysRFA-AI-28-014BiotechLifecycle12 linked
3. GrantNational Institutes of Health12d agoNIH seeks applications for translational genome editing and biologic therapy development for Alzheimer's-related dementias, with a $6 million ceiling.$6M ceilingCloses in 694 daysRFA-NS-28-012BiotechLifecycle12 linked